Tabla de Contenidos:
  • Cover; Copyright; Acknowledgments; Abstract and Benefits; Table of Contents; List of Tables; List of Figures; List of Abbreviations and Acronyms; Executive Summary; Chapter 1.0: Study Significance; Chapter 2.0: Quantitative Microbial Risk Assessment; 2.1 Introduction; 2.2 Materials and Methods; 2.2.1 Exposure Assessment; 2.2.2 Dose-Response Assessment; 2.2.3 Risk Characterization; 2.3 Results and Discussion; 2.3.1 Exposure Assessment; 2.3.1.1 Patient Excreta and Secreta Production to Sewer; 2.3.1.2 Excreta and Secreta Concentrations of EBOV.
  • 2.3.1.3 Hospital Daily Outflow (For internal dilution rate in hospital)2.3.1.4 Interceptor Daily Flow (For dilution from hospital discharge to sewer to point of worker exposure); 2.3.1.5 EBOV Die-Off Rate; 2.3.1.6 Sewer Travel Time from Patient to Point of Worker Exposure; 2.3.1.7 Partition Coefficient (Ratio of aerosol concentration of EBOV to liquid concentration); 2.3.1.8 Respirable Fraction (Fraction of aerosols generated that are respirable); 2.3.1.9 Worker Inhalation Rate; 2.3.1.10 EBOV Removal Fraction by Worker PPE; 2.3.1.11 Time Spent by a Sewer Worker in the Proximity.
  • 2.3.1.12 Conversion from EBOV RNA Copies to PFUs2.3.1.13 Dose of Respirable EBOV Inhaled and Retained in Lungs per Exposure; 2.3.2 Dose-Response Assessment; 2.3.3 Risk Characterization; 2.4 Conclusions; Chapter 3.0: Inactivation Review; 3.1 Background and Results; Appendix A: Ebola Risks/Discharge Frequently Asked Questions; Appendix B: Inactivation Matrix; Glossary of Terms; References.